Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 47-50 , January 2007

Methicillin-resistant Staphyloccocus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage

Received 30 November 2005 ,Accepted 31 May 2006.

References 

  1. Pecoraro RE, Reiber GE, Burgess EM. Causal pathways to amputation: basis for prevention. Diab. Care. 1990;13:513–521
  2. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In:  Harris MI,  Cowie CC,  Reiber GE,  Boyko EJ,  Stern M,  Bennet P editor. Diabetes in America. Washington DC, USA: US Government Printing Office; 1995;p. 409–428
  3. Apelqvist J, Tennval GR, Persson U, Larsson J. Diabetic foot ulcers in a multi-disciplinary setting: an economic analysis of primary healing and healing with amputation. J. Intern. Med. 1994;235:463–471
  4. Ecker ML, Jacobs BS. Lower extremity amputation in diabetic patients. Diabetes. 1970;19:189–195
  5. Nelson RG, Gohdes DM, Everhart JE. Lower extremity amputations in NIDDM. A 12 year follow-up study in Pima Indians. Diab. Care. 1988;11:8–16
  6. Boyko EJ, Ahroni JH, Smith DG. Increased mortality associated with diabetic foot ulcers. Diab. Med. 1996;13:967–972
  7. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diab. Care. 2003;26:491–494
  8. Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br. Med. J. 2000;320:213–216
  9. Duckwork G. Controlling methicillin resistant Staphylococcus aureus. Br. Med. J. 2003;327:1177–1178
  10. Tentolouris N, Jude EB, Smirnof I, Knowles E, Boulton AJM. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diab. Med. 1999;16:767–771
  11. Dang CN, Prasad YDM, Boulton AJM, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diab. Med. 2003;20:159–161
  12. Maser RE, Nielson VK, Bass EB, Manjoo Q, Dorman JS, Kelsey SF, et al. Measuring diabetic neuropathy: assessment and comparison of clinical examination and quantitative scoring testing. Diab. Care. 1989;12:270–275
  13. Public Health Laboratory Services, Investigation of specimens for screening for MRSA, Standard Operating Procedure no. 29, PHLS Technical Services, PHLS HQ, 2002, pp. 1–16.
  14. Boulton AJM. The diabetic foot—from art to science. Diabetologia. 2004;47:1343–1353
  15. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, et al. Diabetic foot ulcer and multidrug resistant organisms: risk factors and impact. Diab. Med. 2004;21:710–715
  16. Wertheim HFL, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JAJW, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364:703–705
  17. Hill RLR, Bates M, Foster AVM, Edmonds ME. Nasal carriage of Staphylococcus aureus in diabetic foot ulcer patients and its relationship to ulcer infection. Diab. Med. 2003;20(Suppl. 2):9
  18. Sharp CS, Bessman AN, Wagner FW, Garland D. Microbiology of deep tissue in diabetic gangrene. Diab. Care. 1978;1:289
  19. Sharp CS, Bessman AN, Wagner FW, Garland D, Reece E. Microbiology of superficial and deep tissue in infected diabetic gangrene. Surg. Gynaecol. Obstet. 1979;149:217
  20. Game FL, Boswell T, Soar C, Houghton E, Treece K, Pound N, et al. Outcome in diabetic foot ulcers with and without methicillin resistant Staphylococcus aureus (MRSA). Diab. Med. 2003;20(Suppl. 2):30
  21. Mantey I, Hill RL, Foster AV, Wilson S, Wade JJ, Edmonds ME. Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. Commun. Dis. Pub. Health. 2000;3:288–290

PII: S0168-8227(06)00327-5

doi: 10.1016/j.diabres.2006.05.021

Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 47-50 , January 2007

Article Tools